Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Jyong Biotech Ltd. (MENS)

$2.36 -12.92% NASDAQ: MENS · 15-min delayed
  • Public · NASDAQ: MENS
  • 27 employees
$150.0MMarket cap
-$4.7MNet income
27Employees
MENSNASDAQ
2025IPO

About Jyong Biotech Ltd.

Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$4.7M
Total assets
$20.8M
Market cap
$150.0M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: MENS
$2.36 -12.92%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.46 $65.62

52-week range

Market cap
$150.0M
Shares outstanding
63.5M
Open
Day range
Prev close
Volume
IPO date
Jun 17, 2025

Jyong Biotech Ltd. (MENS) Stock Price

  • Reported a net loss of $4.7M.
  • Trading 96% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Jyong Biotech Ltd..

Write a review
Newsroom

News about Jyong Biotech Ltd.

News & sentiment via Polygon.io

FAQ

Jyong Biotech Ltd.: frequently asked questions

Is Jyong Biotech Ltd. an American company?

Jyong Biotech Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Jyong Biotech Ltd. publicly traded?

Yes — Jyong Biotech Ltd. is a publicly traded company. Its stock trades under the ticker symbol MENS on the NASDAQ.

What does Jyong Biotech Ltd. do?

Jyong Biotech Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →